Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
By Kasia Lobello, Sujana Reddy, Jeff Musgnung, Ronald Pedersen, Philip T. Ninan
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
By Robert M. Nevels, Samuel T. Gontkovsky, Bryman E. Williams
Paroxetine Use in Medically Ill Patients
By Steven Stout, MD, PhD, Wendy I. Somerset, MD, Andrew Miller, MD, and Dominique L. Musselman, MD, MS
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
By Kimberly A. Yonkers, MD
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
By Karen Dineen Wagner, MD, PhD
Paroxetine Treatment of Major Depressive Disorder
By Martin B. Keller, MD
Paroxetine Treatment of Generalized Anxiety Disorder
By David V. Sheehan, MD, MBA, and C. Gloria Mao, PharmD
Paroxetine Treatment of Depression in Late Life
By Charles F. Reynolds III, MD
Panic Disorder During Pregnancy
By Dana March, BA and Kimberly A. Yonkers, MD
Panel Discussion
Palliative Chemotherapy for Advanced Colorectal Cancer
By Peter Simmonds, FRACP, and Tim Iveson, MD
Palliative Care Options for Advanced Prostate Cancer
By Amir V. Kaisary, MA, ChM, FRCS, and Ross Knight, MRCS
Evidence-Based Medicine
Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study
By Rosaria Di Lorenzo, Michela Cameli, Marisa Bolondi, Giulia Landi, Valentina Moretti, Chiara Piemonte, Gabriella Pollutri